initial public offerings (IPOs) trading on American exchanges

Thursday, October 1, 2020

Pulmonx (LUNG) began trading on the Nasdaq on Thur 1 Oct 20

Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. 
  • Sector(s): Healthcare
  • Industry: Medical Devices
  • Full Time Employees: 253
  • Incorporated in 1995 
  • Headquartered in Redwood City, California
Pulmonx  priced 10 mln share IPO at $19.00 per share, above the expected range of $17-18

No comments:

Post a Comment